| Code | 2193E | ||||||||||
| MA number | 56/0262/22-S | ||||||||||
| Product Form: | tbl 100x25 µg (blis.Al/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Berlin-Chemie AG, Germany | ||||||||||
| Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister Al/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 14.10.2022 |
| Validity: | 14.10.2027 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_L-Thyroxin 25_12_2023.pdf
|
| PIL: |
PIL_L-Thyroxin 25_12_2023.pdf
|
| Safety feature | Yes |
| Data update: | 17.10.2022 |
